- Home
- ARWR vs DAC Comparison
ARWR vs DAC Comparison
Compare ARWR & DAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- DAC
- Stock Information
- Founded
- ARWR 2003
- DAC 1972
- Country
- ARWR United States
- DAC Greece
- Employees
- ARWR N/A
- DAC N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- DAC Marine Transportation
- Sector
- ARWR Health Care
- DAC Consumer Discretionary
- Exchange
- ARWR Nasdaq
- DAC Nasdaq
- Market Cap
- ARWR 1.8B
- DAC 1.6B
- IPO Year
- ARWR 1993
- DAC 2006
- Fundamental
- Price
- ARWR $15.32
- DAC $87.29
- Analyst Decision
- ARWR Buy
- DAC Strong Buy
- Analyst Count
- ARWR 8
- DAC 1
- Target Price
- ARWR $43.71
- DAC $105.00
- AVG Volume (30 Days)
- ARWR 1.5M
- DAC 98.1K
- Earning Date
- ARWR 08-07-2025
- DAC 08-04-2025
- Dividend Yield
- ARWR N/A
- DAC 3.92%
- EPS Growth
- ARWR N/A
- DAC N/A
- EPS
- ARWR N/A
- DAC 24.48
- Revenue
- ARWR $545,209,000.00
- DAC $1,013,968,000.00
- Revenue This Year
- ARWR $21,924.50
- DAC $2.55
- Revenue Next Year
- ARWR N/A
- DAC N/A
- P/E Ratio
- ARWR N/A
- DAC $3.58
- Revenue Growth
- ARWR 1436.97
- DAC 3.10
- 52 Week Low
- ARWR $9.57
- DAC $65.40
- 52 Week High
- ARWR $30.41
- DAC $94.63
- Technical
- Relative Strength Index (RSI)
- ARWR 46.47
- DAC 56.87
- Support Level
- ARWR $15.19
- DAC $85.48
- Resistance Level
- ARWR $16.06
- DAC $88.29
- Average True Range (ATR)
- ARWR 0.68
- DAC 2.06
- MACD
- ARWR -0.23
- DAC -0.02
- Stochastic Oscillator
- ARWR 15.23
- DAC 59.59
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About DAC Danaos Corporation
Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.